Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioMarin Pharmaceutical Inc. buy Stifel Nicolaus

BioMarin Pharmaceutical Inc.
Start price
€86.10
21.12.23 / 50%
Target price
€91.85
21.12.24
Performance (%)
-11.54%
Price
€76.16
09.05.24
Summary
This prediction is currently active. The prediction for BioMarin Pharmaceutical Inc. disappoints with a performance of -11.54%. This prediction currently runs until 21.12.24. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
BioMarin Pharmaceutical Inc. -0.600% -0.600%
iShares Core DAX® 4.094% 4.888%
iShares Nasdaq 100 1.424% -0.445%
iShares Nikkei 225® -1.572% -4.911%
iShares S&P 500 1.822% 0.776%

Comments by Stifel_Nicolaus for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -11.54%
Target price 91.849
Change
Ends at 21.12.24

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $101.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat

Stifel Nicolaus 
0
Report Share
21.12.23

Stopped prediction by Stifel_Nicolaus for BioMarin Pharmaceutical Inc.

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€79.72
01.08.23
€98.41
01.08.24
-4.47%
09.05.24

Stifel Nicolaus 
01.08.23 50%
buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€94.17
28.02.23
€111.20
28.02.24
-13.41%
29.02.24

Stifel Nicolaus 
28.02.23 50%